CHAD THOMAS: Open Payments
NPI 1528030863 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 54 payments from 12 companies in 2025. Trend: 2023 $741 · 2024 $740 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $199 |
| PFIZER INC. | 11 | $154 |
| Gilead Sciences, Inc. | 5 | $114 |
| Janssen Biotech, Inc. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| GENZYME CORPORATION | 2 | $43 |
| Intercept Pharmaceuticals, Inc. | 2 | $36 |
| Celltrion USA Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
Products named: XELJANZ, RINVOQ, DUPIXENT, TREMFYA, CREON, VELSIPITY, OCALIVA, VEGZELMA.
Industry payments across SC — which companies pay providers there.
